

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Novel approaches for treating hypertension | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-80/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-80" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Novel approaches for treating hypertension" />
    
            <meta name="og:title" content="F1000Research Article: Novel approaches for treating hypertension.">
            <meta name="og:description" content="Read the latest article version by Andrew J. Freeman, Antony Vinh, Robert E. Widdop, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="10898">
            <meta name="article-id" content="10117">
            <meta name="dc.title" content="Novel approaches for treating hypertension">
            <meta name="dc.description" content="Hypertension, or high blood pressure, is a prevalent yet modifiable risk factor for cardiovascular disease. While there are many effective treatments available to combat hypertension, patients often require at least two to three medications to control blood pressure, although there are patients who are resistant to such therapies. This short review will briefly update on recent clinical advances and potential emerging therapies and is intended for a cross-disciplinary readership.">
            <meta name="dc.subject" content="hypertension, cardiovascular disease, hypertension therapies, high blood pressure">
            <meta name="dc.creator" content="Freeman, Andrew J.">
            <meta name="dc.creator" content="Vinh, Antony">
            <meta name="dc.creator" content="Widdop, Robert E.">
            <meta name="dc.date" content="2017/01/27">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.10117.1">
            <meta name="dc.source" content="F1000Research 2017 6:80">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="hypertension">
            <meta name="prism.keyword" content="cardiovascular disease">
            <meta name="prism.keyword" content="hypertension therapies">
            <meta name="prism.keyword" content="high blood pressure">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/01/27">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="80">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.10117.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-80">
            <meta name="citation_title" content="Novel approaches for treating hypertension">
            <meta name="citation_abstract" content="Hypertension, or high blood pressure, is a prevalent yet modifiable risk factor for cardiovascular disease. While there are many effective treatments available to combat hypertension, patients often require at least two to three medications to control blood pressure, although there are patients who are resistant to such therapies. This short review will briefly update on recent clinical advances and potential emerging therapies and is intended for a cross-disciplinary readership.">
            <meta name="citation_description" content="Hypertension, or high blood pressure, is a prevalent yet modifiable risk factor for cardiovascular disease. While there are many effective treatments available to combat hypertension, patients often require at least two to three medications to control blood pressure, although there are patients who are resistant to such therapies. This short review will briefly update on recent clinical advances and potential emerging therapies and is intended for a cross-disciplinary readership.">
            <meta name="citation_keywords" content="hypertension, cardiovascular disease, hypertension therapies, high blood pressure">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Andrew J. Freeman">
            <meta name="citation_author_institution" content="Department of Pharmacology and Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia">
            <meta name="citation_author" content="Antony Vinh">
            <meta name="citation_author_institution" content="Department of Pharmacology and Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia">
            <meta name="citation_author" content="Robert E. Widdop">
            <meta name="citation_author_institution" content="Department of Pharmacology and Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia">
            <meta name="citation_publication_date" content="2017/01/27">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="80">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.10117.1">
            <meta name="citation_firstpage" content="80">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-80/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-80.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=10898 /> <input type=hidden id=articleId name=articleId value=10117 /> <input type=hidden id=xmlUrl value="/articles/6-80/v1/xml"/> <input type=hidden id=xmlFileName value="-6-80-v1.xml"> <input type=hidden id=article_uuid value=248cd570-ab15-46fa-be31-1ba40baa7d13 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Novel approaches for treating hypertension"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.10117.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.10117.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-80"
  },
  "headline": "Novel approaches for treating hypertension",
  "datePublished": "2017-01-27T10:03:35",
  "dateModified": "2017-01-27T10:03:35",
  "author": [
    {
      "@type": "Person",
      "name": "Andrew J. Freeman"
    },    {
      "@type": "Person",
      "name": "Antony Vinh"
    },    {
      "@type": "Person",
      "name": "Robert E. Widdop"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Hypertension, or high blood pressure, is a prevalent yet modifiable risk factor for cardiovascular disease. While there are many effective treatments available to combat hypertension, patients often require at least two to three medications to control blood pressure, although there are patients who are resistant to such therapies. This short review will briefly update on recent clinical advances and potential emerging therapies and is intended for a cross-disciplinary readership."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-80/v1",
            "name": "Novel approaches for treating hypertension"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Novel approaches for treating hypertension </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=10898 data-id=10117 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10117.1" data-recommended="" data-doi="10.12688/f1000research.10117.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-80/v1/pdf?article_uuid=248cd570-ab15-46fa-be31-1ba40baa7d13" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-10117-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-10117-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-10117-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Freeman AJ, Vinh A and Widdop RE. Novel approaches for treating hypertension [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):80 (<a class=new-orange href="https://doi.org/10.12688/f1000research.10117.1" target=_blank>https://doi.org/10.12688/f1000research.10117.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-10117-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=10117 id=track-article-signin-10117 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10117?target=/articles/6-80/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10898 /> <input name=articleId type=hidden value=10117 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Novel approaches for treating hypertension</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Andrew J. Freeman,&nbsp;</span><span class="">Antony Vinh,&nbsp;</span><span class=""><a href="mailto:robert.widdop@monash.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Robert E. Widdop</span></a></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Andrew J. Freeman,&nbsp;</span><span class="">Antony Vinh,&nbsp;</span><span class=""><a href="mailto:robert.widdop@monash.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Robert E. Widdop</span></a></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 27 Jan 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.10117.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Pharmacology and Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=14208-19714></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=19891-19715></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Hypertension, or high blood pressure, is a prevalent yet modifiable risk factor for cardiovascular disease. While there are many effective treatments available to combat hypertension, patients often require at least two to three medications to control blood pressure, although there are patients who are resistant to such therapies. This short review will briefly update on recent clinical advances and potential emerging therapies and is intended for a cross-disciplinary readership. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> hypertension, cardiovascular disease, hypertension therapies, high blood pressure </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Robert E. Widdop (<a href="mailto:robert.widdop@monash.edu">robert.widdop@monash.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Robert E. Widdop </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2017 Freeman AJ <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Freeman AJ, Vinh A and Widdop RE. Novel approaches for treating hypertension [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):80 (<a href="https://doi.org/10.12688/f1000research.10117.1" target=_blank>https://doi.org/10.12688/f1000research.10117.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 27 Jan 2017, <b>6</b>(F1000 Faculty Rev):80 (<a href="https://doi.org/10.12688/f1000research.10117.1" target=_blank>https://doi.org/10.12688/f1000research.10117.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 27 Jan 2017, <b>6</b>(F1000 Faculty Rev):80 (<a href="https://doi.org/10.12688/f1000research.10117.1" target=_blank>https://doi.org/10.12688/f1000research.10117.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d53650e170>Introduction</h2><p class="" id=d53650e173>Blood pressure is considered to be elevated at hypertensive levels when systolic blood pressure (SBP) is 140 mmHg and/or diastolic blood pressure is 90 mmHg. Hypertension is generally considered to be one of the strongest modifiable risk factors for cardiovascular disease. Its asymptomatic clinical presentation means that there is a long exposure time that contributes to cardiovascular complications and ultimately leads to a detrimental impact on global health.</p><p class="" id=d53650e176>Pharmacological treatment of hypertension decreases the likelihood of cardiovascular events such as heart attack, heart failure, and stroke occurring<sup><a href="#ref-1">1</a><a href="#ref-3">3</a></sup>, although blood pressure and associated cardiovascular diseases are still on the increase, particularly with our ageing population. The importance of blood pressure lowering can be seen with the outcomes from the recently published SPRINT trial<sup><a href="#ref-4">4</a></sup>. When SBP was intensively controlled to a target of &lt;120 mmHg compared with the standard treatment target of &lt;140 mmHg, intensive anti-hypertensive treatment resulted in ~25% reduction in primary composite outcome of myocardial infarction, acute coronary syndrome, stroke, heart failure, or cardiovascular death. Because of the striking findings, the trial was stopped ahead of time after a median follow-up of 3.3 years. While there is ongoing debate as to the applicability of such findings given the usually less rigorous clinical practice settings occurring in the general community, together with key patient exclusions (e.g. diabetes mellitus and stroke)<sup><a href="#ref-5">5</a></sup>, the high relevance of blood pressure control for organ protection is clearly evident. These findings are consistent with previous meta-analysis data on one million adults that demonstrated an association between increasing cardiovascular risk and blood pressure<sup><a href="#ref-6">6</a></sup>.</p><p class="" id=d53650e198>Many anti-hypertensive therapies are currently being used when lifestyle and behavioural changes are not sufficient. As our undergraduate students quickly learn, the ABCD of commonly prescribed anti-hypertensive agents (i.e. A=inhibitors of angiotensin [Ang] such as Ang-converting enzyme [ACE] inhibitors and Ang type I [AT<sub>1</sub>] receptor antagonists; B=1-adrenoceptor antagonists; C=calcium channel antagonists; D=diuretics) are likely to be key initial choices. However, these drugs do not always adequately control blood pressure or are not appropriate in all hypertensive patients who usually exhibit various co-morbidities. Notwithstanding important issues such as noncompliance, it is still estimated that 1015% of hypertensive patients are resistant to current treatment options, where blood pressure is uncontrolled with three or more different classes of anti-hypertensives, including a diuretic<sup><a href="#ref-7">7</a>,<a href="#ref-8">8</a></sup>. Therefore, the need for new treatment strategies to treat the multi-faceted nature of hypertension, including organ protection, is still an area of intensive research. This short review will discuss emerging novel approaches currently being investigated to treat hypertension.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d53650e214>Combination therapies</h2><p class="" id=d53650e217>Owing to the known clinical efficacy of inhibiting the renin-Ang system (RAS), one could speculate that additive multi-site therapy would result in maximal RAS blockade leading to enhanced anti-hypertensive effects and reduced end organ damage. Indeed, dual RAS blockade did show positive results from short-term studies using blood pressure and albuminuria as surrogate outcomes<sup><a href="#ref-9">9</a><a href="#ref-11">11</a></sup>, but subsequent longer-term trials measuring clinical outcomes have consistently shown that excessive RAS suppression causes adverse effects. For example, the ONTARGET<sup><a href="#ref-12">12</a></sup>, ALTITUDE<sup><a href="#ref-13">13</a></sup>, VA NEPHRON-D<sup><a href="#ref-14">14</a></sup>, and ATMOSPHERE<sup><a href="#ref-15">15</a></sup> trials have confirmed, in a variety of high-risk patients with cardiovascular disease and/or diabetes or heart failure, that combination therapies that simultaneously inhibit a combination of renin, ACE, or AT<sub>1</sub> receptors do not provide additional benefit and in fact exhibit adverse effects such as hypotension, hyperkalaemia, and renal dysfunction. The less favourable risk-benefit ratio of such dual RAS inhibition argues against this therapeutic strategy, and current hypertension guidelines do not recommend combined RAS inhibitor treatment<sup><a href="#ref-1">1</a></sup>.</p><p class="" id=d53650e251>Perhaps reflecting the need for rigorous blood pressure management, in an era of relatively few first-in-class anti-hypertensive agents, there have been numerous fixed double- and triple-dose combinations approved by the FDA this millennia, as recently reviewed<sup><a href="#ref-16">16</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d53650e261>Re-purposing older drugs: mineralocorticoid receptor antagonists for treatment-resistant hypertension</h2><p class="" id=d53650e264>There have been two mineralocorticoid receptor antagonists available for many decades. The second-generation compound eplerenone has reduced affinity for androgen and progesterone receptors compared with the first-generation antagonist spironolactone, but it is also less potent than spironolactone at blocking aldosterone receptors, hence the greater anti-hypertensive potency exhibited by spironolactone<sup><a href="#ref-17">17</a></sup>. Just as the RALES trial<sup><a href="#ref-18">18</a></sup> led to a resurgence in the use of spironolactone and later eplerenone for the treatment of severe heart failure, there is renewed interest in the use of mineralocorticoid receptor antagonists for treatment-resistant hypertension (TRH), if this is caused by aldosterone breakthrough in patients already being treated with an ACE inhibitor or an AT<sub>1</sub> receptor antagonist, leading to sodium retention<sup><a href="#ref-17">17</a></sup>.</p><p class="" id=d53650e282>While there have been a number of short-term (424 weeks duration) placebo-controlled trials that have shown beneficial effects of spironolactone in TRH<sup><a href="#ref-17">17</a></sup>, the strongest evidence for the use of spironolactone in TRH has recently been obtained from the PATHWAY-2 trial<sup><a href="#ref-19">19</a></sup>. All patients who were already receiving A+C+D medications were randomised to receive 12-week sequential treatments of placebo, spironolactone, the <sub>1</sub>-adrenoceptor antagonist doxazosin, and the <sub>1</sub>-adrenoceptor antagonist bisoprolol. In this study, spironolactone reduced home blood pressure recordings by approximately double that of other active treatment arms and showed for the first time a direct drug comparison in the same TRH patients. There was also a significant inverse correlation between plasma renin and blood pressure reduction by spironolactone, suggesting that sodium retention contributed to TRH. In this study<sup><a href="#ref-19">19</a></sup> and earlier studies<sup><a href="#ref-17">17</a></sup>, there was a low incidence of adverse effects. While it has been argued that these results should influence treatment guidelines<sup><a href="#ref-19">19</a></sup>, it will be of great interest to determine long-term TRH outcomes in this particular cohort, including potential adverse outcomes, given the combined use of an ACE inhibitor or an AT<sub>1</sub> receptor antagonist together with mineralocorticoid receptor blockade. Of interest, newer nonsteroidal mineralocorticoid receptor antagonists, such as finerenone, have been developed to target the heart and are being trialled in heart failure<sup><a href="#ref-20">20</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d53650e322>Recent clinical advances</h2><div class=section><a name=d53650e325 class=n-a></a><h3 class=section-title>Vasopeptidase inhibitors</h3><p class="" id=d53650e330>Neprilysin (neutral endopeptidase 24.11) is an enzyme responsible for the breakdown of natriuretic peptides and has long been considered a target for hypertension. Indeed, inhibition of neprilysin increases natriuretic peptide levels, resulting in natriuresis, vasodilation, and functional inhibition of the RAS. However, any blood-pressure-lowering effect of neprilysin inhibition is offset, since this enzyme also degrades peptides such as endothelin-1 and Ang II that cause vasoconstriction. Indeed, combined neprilysin and ACE inhibition, achieved using omapatrilat, evoked greater anti-hypertensive effects than did the ACE inhibitor enalapril alone<sup><a href="#ref-21">21</a></sup>. However, the higher rate of angioedema noted by omapatrilat (most likely involving raised bradykinin levels) in large-scale heart failure trials has led to the discontinuation of this therapeutic strategy, despite clinical efficacy<sup><a href="#ref-22">22</a></sup>. Given that AT<sub>1</sub> receptor antagonists, unlike ACE inhibitors, do not inhibit bradykinin metabolism, other combinations of RAS and neprilysin inhibition have been considered. Indeed, there is much interest in a new combination of equal proportions of the AT<sub>1</sub> receptor antagonist valsartan and a neprilysin inhibitor sacubitril, known as LCZ696.</p><p class="" id=d53650e347>Clinical trial data for LCZ696 demonstrated significantly greater blood pressure reductions compared to valsartan in patients with mild-to-moderate hypertension<sup><a href="#ref-23">23</a></sup>. Anti-hypertensive efficacy of LCZ696 was confirmed in Asian populations with minimal safety and tolerability issues<sup><a href="#ref-24">24</a></sup>. The effect of LCZ696 has also been examined on biomarkers in heart failure patients with preserved ejection fraction (PARAMOUNT)<sup><a href="#ref-25">25</a></sup> and on clinical outcomes in heart failure patients with reduced ejection fraction (PARADIGM-HF)<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>. The latter trial was terminated early since there was a 20% reduction in cardiac death compared with an ACE inhibitor. Interestingly, in all trials, blood pressure reductions were greater than the RAS inhibitor used as the comparator. The beneficial effects of the valsartan/sacubitril combination are described in detail elsewhere<sup><a href="#ref-20">20</a>,<a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup>. Moreover, their striking effects in systolic heart failure patients and the prospects of benefits in future outcome trials for heart failure patients with preserved ejection fraction<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup> begs the question of the potential role of such vasopeptidase inhibition in resistant hypertension.</p><p class="" id=d53650e387>In addition, a dual vasopeptidase inhibitor called daglutril, combining neprilysin and endothelin-converting enzyme inhibition, has been developed and was reported to lower blood pressure in hypertensive type 2 diabetics who were already receiving losartan<sup><a href="#ref-30">30</a></sup>, although its current status is not clear.</p></div><div class=section><a name=d53650e395 class=n-a></a><h3 class=section-title>Anti-diabetic agents</h3><p class="" id=d53650e400>The regulatory requirement to obtain robust cardiovascular safety data to approve new diabetes drugs has increased the number of trials focused on a lack of cardiovascular toxicity rather than examining longer-term studies on the effects of glucose lowering on cardiovascular outcome data<sup><a href="#ref-31">31</a></sup>. However, data are emerging showing that new anti-diabetic drugs can lower blood pressure, perhaps contributing to their therapeutic effects to improve glycaemic control and cardiovascular outcomes. The glucagon-like peptide 1 (GLP-1) analogue liraglutide reduced blood pressure in hypertensive diabetic patients<sup><a href="#ref-32">32</a></sup>. There was a small reduction in blood pressure in the recent LEADER trial, studying over 9,300 patients, in which liraglutide improved cardiovascular outcome (composite of death and non-fatal myocardial infarction or stroke) assessed over 3.55 years<sup><a href="#ref-33">33</a></sup>. Inhibitors of sodium-glucose cotransporter 2, such as empagliflozin, are another new class of anti-diabetic compound that impairs renal glucose reabsorption. In high-risk cardiovascular patients with type 2 diabetes, empagliflozin, added to standard care, lowered the rate of the primary composite cardiovascular outcome and of death from any cause<sup><a href="#ref-34">34</a></sup> and reduced blood pressure versus placebo in patients with type 2 diabetes and hypertension<sup><a href="#ref-35">35</a></sup>. Thus, while these compounds are not strictly anti-hypertensive agents, even modest blood pressure reductions are likely to contribute to other cardiovascular protective mechanisms evoked by these novel anti-diabetic agents<sup><a href="#ref-33">33</a>,<a href="#ref-36">36</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d53650e435>Emerging therapies</h2><div class=section><a name=d53650e438 class=n-a></a><h3 class=section-title>Brain RAS inhibitors</h3><p class="" id=d53650e443>Aminopeptidases are involved in the metabolism of Ang II into shorter Ang peptide fragments. Aminopeptidase A (APA) converts Ang II into Ang III by removing N-terminal aspartate, which can also activate AT<sub>1</sub> or type 2 (AT<sub>2</sub>) receptors. Given the ubiquitous AT<sub>1</sub> receptor expression, Ang II and Ang III both evoke predominant AT<sub>1</sub> receptor-mediated peripheral vasoconstriction and pressor responses. Interestingly, preclinical studies have shown that centrally administered Ang III more effectively raised blood pressure than did Ang II (involving centrally mediated sympathetic nerve stimulation and vasopressin release)<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. Such studies provided the rationale for inhibition of APA as a potential therapeutic strategy to treat hypertension<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. RB150 is a dimer of EC33, which is a selective APA inhibitor that inhibits the conversion of Ang II to Ang III<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. While the clinical efficacy of RB150, also known as QGC001, in the treatment of hypertension is yet to be evaluated, it was well tolerated in healthy male volunteers and did not significantly change heart rate or blood pressure<sup><a href="#ref-40">40</a></sup>. However, it remains to be seen if any centrally mediated anti-hypertensive effect of QGC001, due to decreased bioavailability of Ang III in the brain, is offset by an increase in peripheral Ang II accumulation and consequent vasoconstrictor potential in hypertensive patients. It is also less common nowadays for the development of centrally acting anti-hypertensive drugs because of central side effects.</p></div><div class=section><a name=d53650e485 class=n-a></a><h3 class=section-title>Protective arms of the renin-angiotensin system</h3><p class="" id=d53650e490>In addition to the ACE/AT<sub>1</sub> receptor arm of the RAS, there are two separate but related protective arms of the RAS, so called because their activation generally opposes AT<sub>1</sub> receptor-mediated cardiovascular effects. These include the Ang III/AT<sub>2</sub> receptor arm<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup> and the ACE2/Ang (17)/Mas receptor arm<sup><a href="#ref-41">41</a>,<a href="#ref-43">43</a><a href="#ref-45">45</a></sup>. Within the RAS, there are a number of bioactive Ang peptides in addition to the main effector Ang II. For example, Ang III can also exert more subtle depressor effects and natriuretic responses in preclinical studies that are mediated by AT<sub>2</sub> receptor stimulation<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. A number of selective AT<sub>2</sub> receptor agonists have been developed<sup><a href="#ref-45">45</a></sup>, of which compound 21 (C21) has been the best studied in preclinical hypertension-related models. Indeed, selective AT<sub>2</sub> receptor stimulation reduces hypertension-induced target organ damage, even in the absence of blood pressure reduction in most but not all instances<sup><a href="#ref-42">42</a>,<a href="#ref-46">46</a></sup>. The AT<sub>2</sub> receptor field has been hampered by a lack of selective ligands, but there is great interest in the clinical effects of AT<sub>2</sub> receptor activation and the potential for additive effects of AT<sub>2</sub> receptor agonists with conventional RAS blockade. However, C21 has only entered phase I testing in healthy volunteers at this stage, so this field will be watched with interest.</p><p class="" id=d53650e557>ACE2 is a carboxypeptidase that differs to ACE in that it cleaves one (not two) amino acids from the C-terminal of peptides. In the context of RAS, Ang I and Ang II can be converted by ACE2 to Ang (19) and Ang (17), respectively. In particular, there is much preclinical evidence to indicate that Ang (17) can protect against hypertension-related target organ damage via another G-protein-coupled receptor known as the Mas receptor<sup><a href="#ref-43">43</a>,<a href="#ref-44">44</a>,<a href="#ref-47">47</a></sup>. Given the ability of ACE2 activation to facilitate conversion to the cardioprotective Ang (17) at the expense of (decreasing) levels of the substrate Ang II, research has focused on developing compounds that activate these RAS pathways. Indeed, there are a number of Mas receptor and AT<sub>2</sub> receptor agonists<sup><a href="#ref-20">20</a>,<a href="#ref-45">45</a></sup> that have not yet progressed beyond preclinical studies. Moreover, there are compounds that activate ACE2, such as diminazene aceturate (known as DIZI). Interestingly, this ACE2 activator, structurally related to xanthenone, is used clinically for the treatment of the parasitic disease African trypanosomiasis<sup><a href="#ref-47">47</a></sup>, so there is already translational potential. Similarly, recombinant ACE2 (rACE2) has been used in preclinical studies where it has been reported to lower blood pressure and exert cardioprotective effects<sup><a href="#ref-43">43</a>,<a href="#ref-47">47</a></sup>. Human rACE2 was tested in phase I studies in which single intravenous injections of varying doses were given to healthy subjects<sup><a href="#ref-48">48</a></sup>. Human rACE2 was well tolerated and increased plasma ACE2 without affecting blood pressure and evoked a prolonged, marked suppression of plasma Ang II levels<sup><a href="#ref-48">48</a></sup>. Clearly, additional clinical trial data are required to assess the veracity of this form of therapy.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d53650e605>Renal denervation</h2><p class="" id=d53650e608>Of the non-pharmacological methods being investigated to lower blood pressure<sup><a href="#ref-20">20</a></sup>, the effects of renal denervation are highly relevant and very topical. This interventional treatment was aimed at ablating the effects of augmented sympathetic drive to the kidney, which contributes to the pathogenesis of hypertension primarily owing to sympathetic activation and the release of renin. To this end, Symplicity HTN-1<sup><a href="#ref-49">49</a></sup> and Symplicity HTN-2<sup><a href="#ref-50">50</a></sup> trials used a minimally invasive catheter-based radiofrequency strategy to cause renal nerve denervation in an attempt to lower blood pressure in patients with TRH. These trials were very successful, with the reductions in blood pressure maintained for up to 3 years in many cases<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>. However, procedural concerns were raised about the study design (including lack of blinding or true resistant hypertension<sup><a href="#ref-53">53</a></sup>), which prompted the large multi-centre, sham-controlled, blinded Symplicity HTN-3 trial<sup><a href="#ref-54">54</a></sup>. Surprisingly, no significant blood pressure reductions were observed between the renal denervation and the sham groups after 6 months of follow-up<sup><a href="#ref-54">54</a></sup>, which has resulted in considerable controversy in the field of renal denervation. This discrepancy from earlier trials has been attributed to incomplete ablation after renal denervation, since later analysis revealed that complete renal denervation was rarely achieved in patients in Symplicity HTN-3<sup><a href="#ref-55">55</a></sup>, most likely related to the inexperience of many trial operators and lack of procedural checks<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>. Recently, it has been cogently argued that the rationale for renal denervation for TRH remains valid<sup><a href="#ref-56">56</a></sup>. However, smarter renal denervation trials, with respect to design, location of ablation energy delivery, and testing of achieved denervation<sup><a href="#ref-56">56</a></sup>, are awaited with intense interest. The devil will be in the detail as to how this field, which holds great promise, progresses.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d53650e665>Conclusions</h2><p class="" id=d53650e668>Despite the effectiveness of the currently available anti-hypertensive medications, there is always a need for novel treatment strategies that are more effective in particular hypertensive patient groups and to provide additional resources to tackle TRH. Most of the newer drugs mentioned, including the emerging therapies, are likely to be useful for lowering blood pressure and/or limiting hypertension-related target organ damage.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d53650e1 class=n-a></a><h2 class=main-title id=d53826>Competing interests</h2><p class=metadata-entry><a name=d53650e105 class=n-a></a><p id=d53650e107> The authors declare that they have no competing interests</p></p></div><div class=back-section><a name=d53650e1 class=n-a></a><h2 class=main-title id=d53828>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d53650e675 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d54012>References</h2><div class="section ref-list"><a name=d53650e675 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d53650e682 class=n-a></a>James PA, Oparil S, Carter BL, <i> et al.</i>: 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). <i>JAMA.</i> 2014; <b>311</b>(5): 50720. <a target=xrefwindow id=d53650e693 href="http://www.ncbi.nlm.nih.gov/pubmed/24352797">PubMed Abstract </a> | <a target=xrefwindow id=d53650e696 href="http://dx.doi.org/10.1001/jama.2013.284427">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d53650e705 class=n-a></a>Neal B, MacMahon S, Chapman N, <i> et al.</i>: Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. <i>Lancet.</i> 2000; <b>356</b>(9246): 195564. <a target=xrefwindow id=d53650e716 href="http://www.ncbi.nlm.nih.gov/pubmed/11130523">PubMed Abstract </a> | <a target=xrefwindow id=d53650e719 href="http://dx.doi.org/10.1016/S0140-6736(00)03307-9">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d53650e728 class=n-a></a>Psaty BM, Smith NL, Siscovick DS, <i> et al.</i>: Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. <i>JAMA.</i> 1997; <b>277</b>(9): 73945. <a target=xrefwindow id=d53650e739 href="http://www.ncbi.nlm.nih.gov/pubmed/9042847">PubMed Abstract </a> | <a target=xrefwindow id=d53650e742 href="http://dx.doi.org/10.1001/jama.1997.03540330061036">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725924077"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e751 class=n-a></a>SPRINT Research Group, Wright JT Jr, Williamson JD, <i> et al.</i>: A Randomized Trial of Intensive versus Standard Blood-Pressure Control. <i>N Engl J Med.</i> 2015; <b>373</b>(22): 210316. <a target=xrefwindow id=d53650e762 href="http://www.ncbi.nlm.nih.gov/pubmed/26551272">PubMed Abstract </a> | <a target=xrefwindow id=d53650e765 href="http://dx.doi.org/10.1056/NEJMoa1511939">Publisher Full Text </a> | <a target=xrefwindow id=d53650e769 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4689591">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725924077">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d53650e782 class=n-a></a>Cushman WC, Whelton PK, Fine LJ, <i> et al.</i>: SPRINT Trial Results: Latest News in Hypertension Management. <i>Hypertension.</i> 2016; <b>67</b>(2): 2635. <a target=xrefwindow id=d53650e793 href="http://www.ncbi.nlm.nih.gov/pubmed/26553234">PubMed Abstract </a> | <a target=xrefwindow id=d53650e796 href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.06722">Publisher Full Text </a> | <a target=xrefwindow id=d53650e800 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4768735">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d53650e810 class=n-a></a>Lewington S, Clarke R, Qizilbash N, <i> et al.</i>: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. <i>Lancet.</i> 2002; <b>360</b>(9349): 190313. <a target=xrefwindow id=d53650e821 href="http://www.ncbi.nlm.nih.gov/pubmed/12493255">PubMed Abstract </a> | <a target=xrefwindow id=d53650e824 href="http://dx.doi.org/10.1016/S0140-6736(02)11911-8">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d53650e833 class=n-a></a>Sim JJ, Bhandari SK, Shi J, <i> et al.</i>: Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system. <i>Mayo Clin Proc.</i> 2013; <b>88</b>(10): 1099107. <a target=xrefwindow id=d53650e844 href="http://www.ncbi.nlm.nih.gov/pubmed/24079679">PubMed Abstract </a> | <a target=xrefwindow id=d53650e847 href="http://dx.doi.org/10.1016/j.mayocp.2013.06.017">Publisher Full Text </a> | <a target=xrefwindow id=d53650e851 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3909733">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/10579965"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e860 class=n-a></a>Persell SD: Prevalence of resistant hypertension in the United States, 20032008. <i>Hypertension.</i> 2011; <b>57</b>(6): 107680. <a target=xrefwindow id=d53650e868 href="http://www.ncbi.nlm.nih.gov/pubmed/21502568">PubMed Abstract </a> | <a target=xrefwindow id=d53650e871 href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.170308">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/10579965">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d53650e884 class=n-a></a>Kunz R, Friedrich C, Wolbers M, <i> et al.</i>: Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. <i>Ann Intern Med.</i> 2008; <b>148</b>(1): 3048. <a target=xrefwindow id=d53650e895 href="http://www.ncbi.nlm.nih.gov/pubmed/17984482">PubMed Abstract </a> | <a target=xrefwindow id=d53650e898 href="http://dx.doi.org/10.7326/0003-4819-148-1-200801010-00190">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d53650e907 class=n-a></a>Makani H, Bangalore S, Desouza KA, <i> et al.</i>: Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. <i>BMJ.</i> 2013; <b>346</b>: f360. <a target=xrefwindow id=d53650e918 href="http://www.ncbi.nlm.nih.gov/pubmed/23358488">PubMed Abstract </a> | <a target=xrefwindow id=d53650e921 href="http://dx.doi.org/10.1136/bmj.f360">Publisher Full Text </a> | <a target=xrefwindow id=d53650e925 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3556933">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d53650e934 class=n-a></a>Persson F, Rossing P: Sequential RAAS blockade: is it worth the risk? <i>Adv Chronic Kidney Dis.</i> 2014; <b>21</b>(2): 15965. <a target=xrefwindow id=d53650e942 href="http://www.ncbi.nlm.nih.gov/pubmed/24602465">PubMed Abstract </a> | <a target=xrefwindow id=d53650e945 href="http://dx.doi.org/10.1053/j.ackd.2014.01.003">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1104759"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e955 class=n-a></a>ONTARGET Investigators, Yusuf S, Teo KK, <i> et al.</i>: Telmisartan, ramipril, or both in patients at high risk for vascular events. <i>N Engl J Med.</i> 2008; <b>358</b>(15): 154759. <a target=xrefwindow id=d53650e966 href="http://www.ncbi.nlm.nih.gov/pubmed/18378520">PubMed Abstract </a> | <a target=xrefwindow id=d53650e969 href="http://dx.doi.org/10.1056/NEJMoa0801317">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1104759">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717962604"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e982 class=n-a></a>Parving HH, Brenner BM, McMurray JJ, <i> et al.</i>: Cardiorenal end points in a trial of aliskiren for type 2 diabetes. <i>N Engl J Med.</i> 2012; <b>367</b>(23): 220413. <a target=xrefwindow id=d53650e993 href="http://www.ncbi.nlm.nih.gov/pubmed/23121378">PubMed Abstract </a> | <a target=xrefwindow id=d53650e996 href="http://dx.doi.org/10.1056/NEJMoa1208799">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717962604">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718171017"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1009 class=n-a></a>Fried LF, Emanuele N, Zhang JH, <i> et al.</i>: Combined angiotensin inhibition for the treatment of diabetic nephropathy. <i>N Engl J Med.</i> 2013; <b>369</b>(20): 1892903. <a target=xrefwindow id=d53650e1020 href="http://www.ncbi.nlm.nih.gov/pubmed/24206457">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1023 href="http://dx.doi.org/10.1056/NEJMoa1303154">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718171017">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726263879"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1036 class=n-a></a>McMurray JJ, Krum H, Abraham WT, <i> et al.</i>: Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure. <i>N Engl J Med.</i> 2016; <b>374</b>(16): 152132. <a target=xrefwindow id=d53650e1047 href="http://www.ncbi.nlm.nih.gov/pubmed/27043774">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1050 href="http://dx.doi.org/10.1056/NEJMoa1514859">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726263879">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d53650e1063 class=n-a></a>Paulis L, Rajkovicova R, Simko F: New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon? <i>Curr Hypertens Rep.</i> 2015; <b>17</b>(6): 557. <a target=xrefwindow id=d53650e1071 href="http://www.ncbi.nlm.nih.gov/pubmed/25893478">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1074 href="http://dx.doi.org/10.1007/s11906-015-0557-x">Publisher Full Text </a> | <a target=xrefwindow id=d53650e1077 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4412646">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d53650e1086 class=n-a></a>Narayan H, Webb DJ: New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension. <i>Curr Hypertens Rep.</i> 2016; <b>18</b>(5): 34. <a target=xrefwindow id=d53650e1094 href="http://www.ncbi.nlm.nih.gov/pubmed/27072827">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1097 href="http://dx.doi.org/10.1007/s11906-016-0643-8">Publisher Full Text </a> | <a target=xrefwindow id=d53650e1100 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4829620">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d53650e1110 class=n-a></a>Pitt B, Zannad F, Remme WJ, <i> et al.</i>: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. <i>N Engl J Med.</i> 1999; <b>341</b>(10): 70917. <a target=xrefwindow id=d53650e1121 href="http://www.ncbi.nlm.nih.gov/pubmed/10471456">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1124 href="http://dx.doi.org/10.1056/NEJM199909023411001">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725813579"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1133 class=n-a></a>Williams B, MacDonald TM, Morant S, <i> et al.</i>: Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. <i>Lancet.</i> 2015; <b>386</b>(10008): 205968. <a target=xrefwindow id=d53650e1144 href="http://www.ncbi.nlm.nih.gov/pubmed/26414968">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1147 href="http://dx.doi.org/10.1016/S0140-6736(15)00257-3">Publisher Full Text </a> | <a target=xrefwindow id=d53650e1151 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4655321">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725813579">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d53650e1164 class=n-a></a>Oparil S, Schmieder RE: New approaches in the treatment of hypertension. <i>Circ Res.</i> 2015; <b>116</b>(6): 107495. <a target=xrefwindow id=d53650e1172 href="http://www.ncbi.nlm.nih.gov/pubmed/25767291">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1175 href="http://dx.doi.org/10.1161/CIRCRESAHA.116.303603">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d53650e1184 class=n-a></a>Kostis JB, Packer M, Black HR, <i> et al.</i>: Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. <i>Am J Hypertens.</i> 2004; <b>17</b>(2): 10311. <a target=xrefwindow id=d53650e1195 href="http://www.ncbi.nlm.nih.gov/pubmed/14751650">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1198 href="http://dx.doi.org/10.1016/j.amjhyper.2003.09.014">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d53650e1207 class=n-a></a>Packer M, Califf RM, Konstam MA, <i> et al.</i>: Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE). <i>Circulation.</i> 2002; <b>106</b>(8): 9206. <a target=xrefwindow id=d53650e1218 href="http://www.ncbi.nlm.nih.gov/pubmed/12186794">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1221 href="http://dx.doi.org/10.1161/01.CIR.0000029801.86489.50">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d53650e1230 class=n-a></a>Ruilope LM, Dukat A, Bhm M, <i> et al.</i>: Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study. <i>Lancet.</i> 2010; <b>375</b>(9722): 125566. <a target=xrefwindow id=d53650e1241 href="http://www.ncbi.nlm.nih.gov/pubmed/20236700">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1244 href="http://dx.doi.org/10.1016/S0140-6736(09)61966-8">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d53650e1254 class=n-a></a>Kario K, Sun N, Chiang FT, <i> et al.</i>: Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study. <i>Hypertension.</i> 2014; <b>63</b>(4): 698705. <a target=xrefwindow id=d53650e1265 href="http://www.ncbi.nlm.nih.gov/pubmed/24446062">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1268 href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.02002">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717955094"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1277 class=n-a></a>Solomon SD, Zile M, Pieske B, <i> et al.</i>: The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. <i>Lancet.</i> 2012; <b>380</b>(9851): 138795. <a target=xrefwindow id=d53650e1288 href="http://www.ncbi.nlm.nih.gov/pubmed/22932717">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1291 href="http://dx.doi.org/10.1016/S0140-6736(12)61227-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717955094">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d53650e1304 class=n-a></a>McMurray JJ, Packer M, Desai AS, <i> et al.</i>: Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). <i>Eur J Heart Fail.</i> 2013; <b>15</b>(9): 106273. <a target=xrefwindow id=d53650e1315 href="http://www.ncbi.nlm.nih.gov/pubmed/23563576">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1318 href="http://dx.doi.org/10.1093/eurjhf/hft052">Publisher Full Text </a> | <a target=xrefwindow id=d53650e1322 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3746839">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718552061"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1331 class=n-a></a>McMurray JJ, Packer M, Desai AS, <i> et al.</i>: Angiotensin-neprilysin inhibition versus enalapril in heart failure. <i>N Engl J Med.</i> 2014; <b>371</b>(11): 9931004. <a target=xrefwindow id=d53650e1342 href="http://www.ncbi.nlm.nih.gov/pubmed/25176015">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1345 href="http://dx.doi.org/10.1056/NEJMoa1409077">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718552061">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725800354"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1358 class=n-a></a>Macdonald PS: Combined angiotensin receptor/neprilysin inhibitors: a review of the new paradigm in the management of chronic heart failure. <i>Clin Ther.</i> 2015; <b>37</b>(10): 2199205. <a target=xrefwindow id=d53650e1366 href="http://www.ncbi.nlm.nih.gov/pubmed/26386501">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1369 href="http://dx.doi.org/10.1016/j.clinthera.2015.08.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725800354">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726219005"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1382 class=n-a></a>Hubers SA, Brown NJ: Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition. <i>Circulation.</i> 2016; <b>133</b>(11): 111524. <a target=xrefwindow id=d53650e1390 href="http://www.ncbi.nlm.nih.gov/pubmed/26976916">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1393 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.115.018622">Publisher Full Text </a> | <a target=xrefwindow id=d53650e1396 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4800749">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726219005">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d53650e1410 class=n-a></a>Parvanova A, van der Meer IM, Iliev I, <i> et al.</i>: Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial. <i>Lancet Diabetes Endocrinol.</i> 2013; <b>1</b>(1): 1927. <a target=xrefwindow id=d53650e1421 href="http://www.ncbi.nlm.nih.gov/pubmed/24622263">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1424 href="http://dx.doi.org/10.1016/S2213-8587(13)70029-9">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d53650e1433 class=n-a></a>Holman RR, Sourij H, Califf RM: Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes. <i>Lancet.</i> 2014; <b>383</b>(9933): 200817. <a target=xrefwindow id=d53650e1441 href="http://www.ncbi.nlm.nih.gov/pubmed/24910232">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1444 href="http://dx.doi.org/10.1016/S0140-6736(14)60794-7">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d53650e1453 class=n-a></a>von Scholten BJ, Lajer M, Goetze JP, <i> et al.</i>: Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment. <i>Diabet Med.</i> 2015; <b>32</b>(3): 34352. <a target=xrefwindow id=d53650e1464 href="http://www.ncbi.nlm.nih.gov/pubmed/25251901">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1467 href="http://dx.doi.org/10.1111/dme.12594">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726419704"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1476 class=n-a></a>Marso SP, Daniels GH, Brown-Frandsen K, <i> et al.</i>: Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. <i>N Engl J Med.</i> 2016; <b>375</b>(4): 31122. <a target=xrefwindow id=d53650e1487 href="http://www.ncbi.nlm.nih.gov/pubmed/27295427">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1490 href="http://dx.doi.org/10.1056/NEJMoa1603827">Publisher Full Text </a> | <a target=xrefwindow id=d53650e1494 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4985288">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726419704">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725794423"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1507 class=n-a></a>Zinman B, Wanner C, Lachin JM, <i> et al.</i>: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. <i>N Engl J Med.</i> 2015; <b>373</b>(22): 211728. <a target=xrefwindow id=d53650e1518 href="http://www.ncbi.nlm.nih.gov/pubmed/26378978">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1521 href="http://dx.doi.org/10.1056/NEJMoa1504720">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725794423">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d53650e1534 class=n-a></a>Tikkanen I, Narko K, Zeller C, <i> et al.</i>: Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension. <i>Diabetes Care.</i> 2015; <b>38</b>(3): 4208. <a target=xrefwindow id=d53650e1545 href="http://www.ncbi.nlm.nih.gov/pubmed/25271206">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1548 href="http://dx.doi.org/10.2337/dc14-1096">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d53650e1558 class=n-a></a>Ussher JR, Drucker DJ: Cardiovascular actions of incretin-based therapies. <i>Circ Res.</i> 2014; <b>114</b>(11): 1788803. <a target=xrefwindow id=d53650e1566 href="http://www.ncbi.nlm.nih.gov/pubmed/24855202">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1569 href="http://dx.doi.org/10.1161/CIRCRESAHA.114.301958">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d53650e1578 class=n-a></a>Ganten D, Hermann K, Bayer C, <i> et al.</i>: Angiotensin synthesis in the brain and increased turnover in hypertensive rats. <i>Science.</i> 1983; <b>221</b>(4613): 86971. <a target=xrefwindow id=d53650e1589 href="http://www.ncbi.nlm.nih.gov/pubmed/6879184">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1592 href="http://dx.doi.org/10.1126/science.6879184">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d53650e1601 class=n-a></a>Gao J, Marc Y, Iturrioz X, <i> et al.</i>: A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors. <i>Clin Sci (Lond).</i> 2014; <b>127</b>(3): 13548. <a target=xrefwindow id=d53650e1612 href="http://www.ncbi.nlm.nih.gov/pubmed/24697296">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1615 href="http://dx.doi.org/10.1042/CS20130396">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d53650e1624 class=n-a></a>Marc Y, Gao J, Balavoine F, <i> et al.</i>: Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats. <i>Hypertension.</i> 2012; <b>60</b>(2): 4118. <a target=xrefwindow id=d53650e1635 href="http://www.ncbi.nlm.nih.gov/pubmed/22710644">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1638 href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.190942">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d53650e1647 class=n-a></a>Balavoine F, Azizi M, Bergerot D, <i> et al.</i>: Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug. <i>Clin Pharmacokinet.</i> 2014; <b>53</b>(4): 38595. <a target=xrefwindow id=d53650e1658 href="http://www.ncbi.nlm.nih.gov/pubmed/24337978">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1661 href="http://dx.doi.org/10.1007/s40262-013-0125-y">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d53650e1670 class=n-a></a>Jones ES, Vinh A, McCarthy CA, <i> et al.</i>: AT2 receptors: functional relevance in cardiovascular disease. <i>Pharmacol Ther.</i> 2008; <b>120</b>(3): 292316. <a target=xrefwindow id=d53650e1681 href="http://www.ncbi.nlm.nih.gov/pubmed/18804122">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1684 href="http://dx.doi.org/10.1016/j.pharmthera.2008.08.009">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d53650e1694 class=n-a></a>Carey RM: AT2 Receptors: Potential Therapeutic Targets for Hypertension. <i>Am J Hypertens.</i> 2016; pii: hpw121. <a target=xrefwindow id=d53650e1699 href="http://www.ncbi.nlm.nih.gov/pubmed/27664954">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1702 href="http://dx.doi.org/10.1093/ajh/hpw121">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d53650e1711 class=n-a></a>Jiang F, Yang J, Zhang Y, <i> et al.</i>: Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. <i>Nat Rev Cardiol.</i> 2014; <b>11</b>(7): 41326. <a target=xrefwindow id=d53650e1722 href="http://www.ncbi.nlm.nih.gov/pubmed/24776703">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1725 href="http://dx.doi.org/10.1038/nrcardio.2014.59">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1007137"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1734 class=n-a></a>Santos RA, Simoes e Silva AC, Maric C, <i> et al.</i>: Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. <i>Proc Natl Acad Sci U S A.</i> 2003; <b>100</b>(14): 825863. <a target=xrefwindow id=d53650e1745 href="http://www.ncbi.nlm.nih.gov/pubmed/12829792">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1748 href="http://dx.doi.org/10.1073/pnas.1432869100">Publisher Full Text </a> | <a target=xrefwindow id=d53650e1752 href="http://www.ncbi.nlm.nih.gov/pmc/articles/166216">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1007137">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725388870"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1765 class=n-a></a>Te Riet L, van Esch JH, Roks AJ, <i> et al.</i>: Hypertension: renin-angiotensin-aldosterone system alterations. <i>Circ Res.</i> 2015; <b>116</b>(6): 96075. <a target=xrefwindow id=d53650e1776 href="http://www.ncbi.nlm.nih.gov/pubmed/25767283">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1779 href="http://dx.doi.org/10.1161/CIRCRESAHA.116.303587">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725388870">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d53650e1792 class=n-a></a>McCarthy CA, Widdop RE, Denton KM, <i> et al.</i>: Update on the angiotensin AT<sub>2</sub> receptor. <i>Curr Hypertens Rep.</i> 2013; <b>15</b>(1): 2530. <a target=xrefwindow id=d53650e1806 href="http://www.ncbi.nlm.nih.gov/pubmed/23224511">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1810 href="http://dx.doi.org/10.1007/s11906-012-0321-4">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726513990"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1819 class=n-a></a>Velkoska E, Patel SK, Burrell LM: Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pressure regulation. <i>Curr Opin Nephrol Hypertens.</i> 2016; <b>25</b>(5): 38495. <a target=xrefwindow id=d53650e1827 href="http://www.ncbi.nlm.nih.gov/pubmed/27367913">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1830 href="http://dx.doi.org/10.1097/MNH.0000000000000254">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726513990">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d53650e1844 class=n-a></a>Haschke M, Schuster M, Poglitsch M, <i> et al.</i>: Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. <i>Clin Pharmacokinet.</i> 2013; <b>52</b>(9): 78392. <a target=xrefwindow id=d53650e1855 href="http://www.ncbi.nlm.nih.gov/pubmed/23681967">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1858 href="http://dx.doi.org/10.1007/s40262-013-0072-7">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1157905"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1867 class=n-a></a>Krum H, Schlaich M, Whitbourn R, <i> et al.</i>: Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. <i>Lancet.</i> 2009; <b>373</b>(9671): 127581. <a target=xrefwindow id=d53650e1878 href="http://www.ncbi.nlm.nih.gov/pubmed/19332353">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1881 href="http://dx.doi.org/10.1016/S0140-6736(09)60566-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1157905">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/6522956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1894 class=n-a></a>Symplicity HTN-2 Investigators, Esler MD, Krum H, <i> et al.</i>: Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. <i>Lancet.</i> 2010; <b>376</b>(9756): 19039. <a target=xrefwindow id=d53650e1905 href="http://www.ncbi.nlm.nih.gov/pubmed/21093036">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1908 href="http://dx.doi.org/10.1016/S0140-6736(10)62039-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/6522956">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718436364"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1921 class=n-a></a>Esler MD, Bhm M, Sievert H, <i> et al.</i>: Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. <i>Eur Heart J.</i> 2014; <b>35</b>(26): 17529. <a target=xrefwindow id=d53650e1932 href="http://www.ncbi.nlm.nih.gov/pubmed/24898552">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1935 href="http://dx.doi.org/10.1093/eurheartj/ehu209">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718436364">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718170923"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e1948 class=n-a></a>Krum H, Schlaich MP, Sobotka PA, <i> et al.</i>: Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. <i>Lancet.</i> 2014; <b>383</b>(9917): 6229. <a target=xrefwindow id=d53650e1959 href="http://www.ncbi.nlm.nih.gov/pubmed/24210779">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1962 href="http://dx.doi.org/10.1016/S0140-6736(13)62192-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718170923">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d53650e1975 class=n-a></a>Persu A, Renkin J, Thijs L, <i> et al.</i>: Renal denervation: ultima ratio or standard in treatment-resistant hypertension. <i>Hypertension.</i> 2012; <b>60</b>(3): 596606. <a target=xrefwindow id=d53650e1986 href="http://www.ncbi.nlm.nih.gov/pubmed/22851728">PubMed Abstract </a> | <a target=xrefwindow id=d53650e1989 href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.195263">Publisher Full Text </a> | <a target=xrefwindow id=d53650e1993 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3607230">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718329296"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d53650e2003 class=n-a></a>Bhatt DL, Kandzari DE, O'Neill WW, <i> et al.</i>: A controlled trial of renal denervation for resistant hypertension. <i>N Engl J Med.</i> 2014; <b>370</b>(15): 1393401. <a target=xrefwindow id=d53650e2014 href="http://www.ncbi.nlm.nih.gov/pubmed/24678939">PubMed Abstract </a> | <a target=xrefwindow id=d53650e2017 href="http://dx.doi.org/10.1056/NEJMoa1402670">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718329296">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d53650e2030 class=n-a></a>Kandzari DE, Bhatt DL, Brar S, <i> et al.</i>: Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. <i>Eur Heart J.</i> 2015; <b>36</b>(4): 21927. <a target=xrefwindow id=d53650e2041 href="http://www.ncbi.nlm.nih.gov/pubmed/25400162">PubMed Abstract </a> | <a target=xrefwindow id=d53650e2044 href="http://dx.doi.org/10.1093/eurheartj/ehu441">Publisher Full Text </a> | <a target=xrefwindow id=d53650e2048 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4301597">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d53650e2057 class=n-a></a>Esler M, Guo L: The future of renal denervation. <i>Auton Neurosci.</i> 2016; pii: S1566-0702(16)30125-4. <a target=xrefwindow id=d53650e2062 href="http://www.ncbi.nlm.nih.gov/pubmed/27546827">PubMed Abstract </a> | <a target=xrefwindow id=d53650e2065 href="http://dx.doi.org/10.1016/j.autneu.2016.08.004">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Jan 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-80/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-80/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Pharmacology and Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-80/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 27 Jan 2017, 6:80 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.10117.1">https://doi.org/10.12688/f1000research.10117.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2017 Freeman AJ <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=10898 data-id=10117 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10117.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-80/v1/pdf?article_uuid=248cd570-ab15-46fa-be31-1ba40baa7d13" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.10117.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Freeman AJ, Vinh A and Widdop RE. Novel approaches for treating hypertension [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):80 (<a href="https://doi.org/10.12688/f1000research.10117.1" target=_blank>https://doi.org/10.12688/f1000research.10117.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=10117 id=mobile-track-article-signin-10117 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10117?target=/articles/6-80/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10898 /> <input name=articleId type=hidden value=10117 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Gabriel Navar</strong>, Hypertension and Renal Centre of Excellence, Tulane University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Robert M. Carey</strong>, University of Virginia Health System, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Jan 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-80/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-80/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=14208-19714></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=19891-19715></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-80/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>27 Jan 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Gabriel Navar</strong>, Hypertension and Renal Centre of Excellence, Tulane University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Robert M. Carey</strong>, University of Virginia Health System, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-80/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-80/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Novel approaches for treating hypertension".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-80/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-80/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-80/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Freeman AJ et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-80/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-80",
            templates : {
                twitter : "Novel approaches for treating hypertension. Freeman AJ et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-80/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Novel approaches for treating hypertension", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Novel approaches for treating hypertension", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/10117/10898")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "10898");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "19714": 0,
                           "19715": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "0b45f553-caa1-43ff-a81b-133b6af21b9d";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-80.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-80.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-80.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-80.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-80.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>